Rallybio Corporation Announces New Employment Agreement with Chief Medical Officer, Steven Ryder, Including Enhanced Compensation and Benefits Package
Rallybio Corporation has announced a new employment agreement with its Chief Medical Officer, Dr. Steven Ryder, effective June 25, 2025. Under this agreement, Dr. Ryder will receive an annual base salary of $531,227 and will be eligible for an annual target bonus of up to 40% of his salary, contingent upon meeting individual and company performance goals. The agreement stipulates an initial one-year term, automatically renewing for successive one-year terms unless either party provides a 60-day notice to terminate. In the event of termination following a change in control, Dr. Ryder will be entitled to severance benefits including a 1.5 times payment of his annual salary and target bonus, plus health premium coverage, and immediate vesting of certain equity awards.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rallybio Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001739410-25-000093), on June 27, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。